Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DAWN NASDAQ:FLYW On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDAWNDay One Biopharmaceuticals$21.53$19.41$5.64▼$21.53$2.22B-1.741.52 million shs2.99 million shsFLYWFlywire$16.35+3.3%$13.24$9.97▼$18.05$1.95B1.32.38 million shs1.60 million shsThe 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDAWNDay One Biopharmaceuticals0.00%0.00%+0.19%+95.73%+240.13%FLYWFlywire-4.98%-9.59%+33.59%+46.71%+42.61%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDAWNDay One Biopharmaceuticals$21.53$19.41$5.64▼$21.53$2.22B-1.741.52 million shs2.99 million shsFLYWFlywire$16.35+3.3%$13.24$9.97▼$18.05$1.95B1.32.38 million shs1.60 million shsThe 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDAWNDay One Biopharmaceuticals0.00%0.00%+0.19%+95.73%+240.13%FLYWFlywire-4.98%-9.59%+33.59%+46.71%+42.61%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDAWNDay One Biopharmaceuticals 2.00Hold$23.298.15% UpsideFLYWFlywire 2.57Moderate Buy$18.1711.11% UpsideCurrent Analyst Ratings BreakdownLatest FLYW and DAWN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/7/2026FLYWFlywire Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (D) ➝ Hold (C-)5/7/2026FLYWFlywire CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$13.00 ➝ $16.005/6/2026FLYWFlywire UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$14.00 ➝ $18.005/6/2026FLYWFlywire Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$17.00 ➝ $20.005/6/2026FLYWFlywire Raymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$21.005/6/2026FLYWFlywire The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral$17.005/6/2026FLYWFlywire BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$17.00 ➝ $20.004/21/2026FLYWFlywire Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)3/11/2026DAWNDay One Biopharmaceuticals JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight ➝ Neutral$27.00 ➝ $21.503/10/2026DAWNDay One Biopharmaceuticals HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy ➝ Neutral$22.00 ➝ $21.503/9/2026DAWNDay One Biopharmaceuticals WedbushSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform ➝ Neutral$30.00 ➝ $21.50(Data available from 5/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDAWNDay One Biopharmaceuticals$158.18M14.06N/AN/A$4.30 per share5.01FLYWFlywire$623.03M3.24$0.42 per share38.82$6.91 per share2.37Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDAWNDay One Biopharmaceuticals-$107.32M-$1.03N/A2,153.00N/A-67.85%-23.43%-20.69%N/AFLYWFlywire$13.50M$0.2371.0926.801.134.45%3.78%2.61%N/ALatest FLYW and DAWN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/5/2026Q1 2026FLYWFlywire$0.03$0.10+$0.07$0.10$170.24 million$184.00 million2/24/2026Q4 2025DAWNDay One Biopharmaceuticals-$0.17-$0.21-$0.04-$0.2060$49.81 million$53.72 million2/24/2026Q4 2025FLYWFlywire-$0.01$105.55+$105.56N/A$144.96 million$157.54 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthDAWNDay One BiopharmaceuticalsN/AN/AN/AN/AN/AFLYWFlywireN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDAWNDay One BiopharmaceuticalsN/A8.027.91FLYWFlywireN/A1.751.75Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDAWNDay One Biopharmaceuticals87.95%FLYWFlywire95.90%Insider OwnershipCompanyInsider OwnershipDAWNDay One Biopharmaceuticals6.20%FLYWFlywire4.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDAWNDay One Biopharmaceuticals60103.33 million96.93 millionOptionableFLYWFlywire1,400123.42 million115.87 millionOptionableFLYW and DAWN HeadlinesRecent News About These CompaniesFlywire (FLYW) price target increased by 11.92% to 18.481 hour ago | msn.comFlywire to Attend Upcoming Investor ConferencesMay 14 at 5:25 PM | globenewswire.comMonday.com, Flywire, Oracle, CLEAR Secure, and UiPath shares are soaring, what you need to knowMay 14 at 5:21 PM | msn.comFirst Eagle Investment Management LLC Increases Stock Holdings in Flywire Corporation $FLYWMay 14 at 3:39 AM | marketbeat.comAsure Software, Flywire, Procore Technologies, Varonis Systems, and Fastly stocks trade down, what you need to knowMay 13 at 3:23 PM | msn.comZoomInfo, GoDaddy, Flywire, and Sprinklr shares plummet, what you need to knowMay 12 at 9:50 AM | msn.comVanguard Group Inc. Sells 215,688 Shares of Flywire Corporation $FLYWMay 12 at 7:05 AM | marketbeat.comPeter Butterfield Sells 1,480 Shares of Flywire (NASDAQ:FLYW) StockMay 12 at 5:19 AM | insidertrades.comInsider Selling: Flywire (NASDAQ:FLYW) Insider Sells $256,005.90 in StockMay 11 at 4:20 AM | americanbankingnews.comMichael Massaro Sells 50,000 Shares of Flywire (NASDAQ:FLYW) StockMay 10, 2026 | americanbankingnews.comPhillip John Riese Sells 37,921 Shares of Flywire (NASDAQ:FLYW) StockMay 10, 2026 | americanbankingnews.comFlywire (NASDAQ:FLYW) Price Target Raised to $16.00May 10, 2026 | americanbankingnews.comMohit Kansal Sells 16,101 Shares of Flywire (NASDAQ:FLYW) StockMay 9, 2026 | insidertrades.comWhy Flywire Corporation’s (FLYW) Stock Is Up 15.07%May 8, 2026 | aaii.comAGlobal Payments and Flywire post strong Q1 earnings beatsMay 8, 2026 | msn.comFlywire (FLYW) Soars to 52-Week High After Swing to ProfitsMay 8, 2026 | insidermonkey.comWhich Is a Better Investment, Flywire Corporation or NCR Atleos Corporation Stock?May 8, 2026 | aaii.comAWhich Is a Better Investment, Flywire Corporation or PennyMac Financial Services, Inc. Stock?May 8, 2026 | aaii.comAFlywire Momentum Sparks Nasdaq Index Fund CuriosityMay 8, 2026 | kalkinemedia.comKMohit Kansal Sells 16,101 Shares of Flywire (NASDAQ:FLYW) StockMay 8, 2026 | marketbeat.comFlywire (NASDAQ:FLYW) Director Phillip John Riese Sells 37,921 SharesMay 8, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeFLYW and DAWN Company DescriptionsDay One Biopharmaceuticals NASDAQ:DAWNDay One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.Flywire NASDAQ:FLYW$16.35 +0.52 (+3.28%) Closing price 04:00 PM EasternExtended Trading$16.33 -0.02 (-0.15%) As of 07:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Flywire Corporation, together with its subsidiaries, operates as a payments enablement and software company in the United States and internationally. Its payment platform and network, and vertical-specific software help clients to get paid and help their customers to pay. The company's platform facilitates payment flows across multiple currencies, payment types, and payment options, as well as provides direct connections to alternative payment methods, such as Alipay, Boleto, PayPal/Venmo, and Trustly. It serves education, healthcare, travel, and business to business organizations. The company was formerly known as peerTransfer Corporation and changed its name to Flywire Corporation in December 2016. Flywire Corporation was incorporated in 2009 and is headquartered in Boston, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas YETI Rallies After Earnings Beat and Raised Outlook Cisco’s Vertical Rally May Still Be in the Early Innings Dividend Growth or High Yield: The Income Investor's Bet Nebius Upside Expands as AI Feedback Loop Intensifies Oklo Stock Could Be Ready for Another Massive Run Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell Qualcomm Stock Doubles: New Era? Or Another False Start? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
